Stocks
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -82.6 | -200.9 | 39.9 | -291.0 | -144.2 | -150.3 | ||
| Changes by years, y/y, % | +112% | +143% | -120% | -829% | -50% | +29.9% | |||
Amylyx Pharmaceuticals. EBITDA US GAAP, bln rub
Amylyx Pharmaceuticals. EBITDA US GAAP, changes, %
Amylyx Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -37.6 | -41.3 | -34.3 | -30.9 | -41.2 | -150.3 | |
| Changes by years, y/y, % | -69% | -22% | -55% | -24% | +9% | |||
| Changes by quarters, q/q, % | -7% | +10% | -17% | -10% | +33% | |||
